Long-term effects of cryopreservation on clinically prepared hematopoietic progenitor cell products

Once frozen, HPC products were stable for up to 14.6 years at <−150°C. Post-thaw viability was found to correlate negatively with pre-freeze granulocyte content and positively with pre-freeze lymphocyte content.